Serum 1,5-anhydroglucitol levels in patients with fulminant type 1 diabetes are lower than those in patients with type 2 diabetes

Clinical Biochemistry

Volumn 43, Issue 15, 2010, Pages 1265-1267

  Koga, Masafumi ^a   Murai, Jun ^a   Saito, Hiroshi ^a   Mukai, Mikio ^a   Kasayama, Soji ^b   Imagawa, Akihisa ^c   Hanafusa, Toshiaki ^d  

^a Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^b NISSAY HOSPITAL   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

1,5 AG; Fulminant type 1 diabetes mellitus; HbA1c

Indexed keywords

1,5 ANHYDROSORBITOL; HEMOGLOBIN A1C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FULMINANT INSULIN DEPENDENT DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 77956789819     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.08.001     Document Type: Article

References (16)

1. Imagawa A., Hanafusa T., Miyagawa J., Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med 2000, 342:301-307.
2. Imagawa A., Hanafusa T., Uchigata Y., et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diab Care 2003, 26:2345-2352.
3. Cohen M.P. Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy?. J Diabet Complications 1998, 2:214-217.
4. Koenig R.J., Peterson C.M., Jones R.L., Saudek C., Lehrman M., Cerami A. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med 1976, 295:417-420.
5. Bunn H.F., Gabbay K.H., Gallop P.M. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978, 20:21-27.
6. Tahara Y., Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diab Care 1995, 18:440-447.
7. Takahashi S., Uchino H., Shimizu T., et al. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 2007, 54:139-144.
8. Koga M., Murai J., Saito H., et al. Serum glycated albumin to hemoglobin A1C ratio is a suitable index for diagnosis of fulminant type 1 diabetes mellitus. Ann Clin Biochem 2010, 47:313-317.
9. Yamanouchi T., Tachibana Y., Sekino N., et al. Origin and disposal of 1, 5-anhydroglucitol, a major polyol in the human body. Am J Physiol 1992, 263:E268-E273.
10. Yamanouchi T., Akanuma H., Nakamura T., Akaoka I., Akanuma Y. Reduction of plasma 1, 5-anhydroglucitol (1-deoxy-glucose) concentration in diabetic patients. Diabetologia 1988, 31:41-45.
11. Yamanouchi T., Ogata N., Tagaya T., et al. Clinical usefulness of serum 1, 5-anhydroglucitol in monitoring glycaemic control. Lancet 1996, 347:1514-1518.
12. Tominaga M., Makino H., Yoshino G., et al. Japanese standard reference material for JDS Lot 2 haemoglobin A1c. I: Comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories. Ann Clin Biochem 2005, 42:41-46.
13. Koga M., Murai J., Saito H., et al. Close relationship between serum concentrations of 1, 5-anhydroglucitol and uric acid in non-diabetic male subjects implies common renal transport system. Clin Chim Acta 2009, 410:70-73.
14. Hanafusa T., Imagawa A., Iwahashi H., et al. Epidemiological and clinical analysis and proposal of diagnostic criteria. J Jpn Diab Soc 2005, 48(1):A1-A13. (In Japanese).
15. Yamanouchi T., Akanuma H., Asano T., Konishi C., Akaoka I., Akanuma Y. Reduction and recovery of plasma 1, 5-anhydro-D-glucitol level in diabetes mellitus. Diabetes 1987, 36:709-715.
16. Yamanouchi T., Akanuma Y. Serum 1, 5-anhydroglucitol (1, 5-AG): new clinical marker for glycemic control. Diabetes Res Clin Pract 1994, 24:S261-S268.